'' (''Nat Biotechnol''; ISSN 1087-0156) is an academic journal covering the science and business of
Biotechnology .
''Nature Biotechnology'' is a continuation of ''Bio/technology'' (''Biotechnology (NY)''; ISSN 0733-222X), which was founded in
1983 and renamed in
1996 . It is published monthly by the
Nature Publishing Group , a division of
Macmillan Publishers Ltd . Like other ''Nature'' journals, there is no external Editorial Board; editorial decisions are made by an in-house team, although
Peer Review by external expert referees forms a part of the review process.
Its 2005
Impact Factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals ''
Science '' and ''
Nature '' for the same period were 30.927 and 29.273, respectively.
The current editor of ''Nature Biotechnology'' is Andrew Marshall. The founding editor of ''Bio/technology'' was Christopher Edwards.
